Ultrasound assessment of the rectus femoris in patients with chronic obstructive pulmonary disease predicts poor exercise tolerance: an exploratory study
- PMID: 34563152
- PMCID: PMC8466975
- DOI: 10.1186/s12890-021-01663-8
Ultrasound assessment of the rectus femoris in patients with chronic obstructive pulmonary disease predicts poor exercise tolerance: an exploratory study
Abstract
Background: Reduced exercise tolerance is an important clinical feature of chronic obstructive pulmonary disease (COPD) and is associated with poor prognosis. The 6-min walk test (6MWT) is widely used to assess exercise capacity; however, it is not commonly administered in primary medical institutions because it requires a suitable site and professional training. Ultrasound has great potential for evaluating skeletal muscle dimensions in COPD. However, whether skeletal muscle ultrasound can predict impaired exercise tolerance is unclear.
Methods: The study included 154 stable patients with COPD, who were randomly divided into a development set and a validation set. The thickness (RFthick) and cross-sectional area (RFcsa) of the rectus femoris were measured using ultrasound. Standardized RFthick (STD- RFthick) and Standardized RFcsa (STD-RFcsa) were obtained via standardization of RFthick and RFcsa by patients' height.
Results: Strong correlations were observed between the 6MWD and RFthick (r = 0.84, p < 0.001) and between the 6MWD and RFcsa (r = 0.81, p < 0.001). In the development set, the optimal cut-off values for men and women for predicting poor exercise tolerance were < 3.098 cm/m and < 3.319 cm/m for STD-RFthick and < 4.052 cm2/m and < 4.366 cm2/m for STD-RFcsa, respectively. In the validation set, the area under the curve (AUC) values for the prediction of a 6MWD < 350 by STD-RFthick and STD-RFcsa were 0.881 and 0.903, respectively. Finally, the predictive efficacy of STD-RFthick (AUC: 0.922), STD-RFcsa (AUC: 0.904), and the derived nomogram model (AUC: 0.98) for exercise tolerance was superior to that of the sit-to-stand test and traditional clinical features.
Conclusions: Rectus femoris ultrasound has potential clinical application to predict impaired exercise tolerance in patients with COPD.
Keywords: COPD; Exercise tolerance; Rectus femoris; Ultrasound.
© 2021. The Author(s).
Conflict of interest statement
The authors have declared that no competing interest exists.
Figures
Similar articles
-
Ultrasound Assessment of the Rectus Femoris in Patients with Chronic Obstructive Pulmonary Disease Predicts Sarcopenia.Int J Chron Obstruct Pulmon Dis. 2022 Nov 2;17:2801-2810. doi: 10.2147/COPD.S386278. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36348815 Free PMC article.
-
Ultrasonic Elastography of the Rectus Femoris, a Potential Tool to Predict Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease.Front Physiol. 2022 Jan 5;12:783421. doi: 10.3389/fphys.2021.783421. eCollection 2021. Front Physiol. 2022. PMID: 35069243 Free PMC article.
-
A comparative study of the five-repetition sit-to-stand test and the 30-second sit-to-stand test to assess exercise tolerance in COPD patients.Int J Chron Obstruct Pulmon Dis. 2018 Sep 10;13:2833-2839. doi: 10.2147/COPD.S173509. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30237707 Free PMC article.
-
Six-Minute Walk Test: Clinical Role, Technique, Coding, and Reimbursement.Chest. 2020 Mar;157(3):603-611. doi: 10.1016/j.chest.2019.10.014. Epub 2019 Nov 2. Chest. 2020. PMID: 31689414 Free PMC article. Review.
-
Sit-to-stand tests for COPD: A literature review.Respir Med. 2017 Jul;128:70-77. doi: 10.1016/j.rmed.2017.05.003. Epub 2017 May 15. Respir Med. 2017. PMID: 28610673 Review.
Cited by
-
The role of superb micr ole of superb microvascular imaging in detecting low-gr ascular imaging in detecting low-grade inflammation among adults and those with chronic kidney disease: A preliminary study.Turk J Med Sci. 2023 Jun;53(3):692-700. doi: 10.55730/1300-0144.5632. Epub 2023 Jun 19. Turk J Med Sci. 2023. PMID: 37476893 Free PMC article.
-
Resistin as a Systemic Inflammation-Related Biomarker for Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease.Front Nutr. 2022 Jul 12;9:921399. doi: 10.3389/fnut.2022.921399. eCollection 2022. Front Nutr. 2022. PMID: 35903456 Free PMC article.
-
Growth Differentiation Factor-15 as a Biomarker for Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease.Front Nutr. 2022 Jun 30;9:897097. doi: 10.3389/fnut.2022.897097. eCollection 2022. Front Nutr. 2022. PMID: 35845807 Free PMC article.
-
Associations between bone mineral density and chronic obstructive pulmonary disease.J Int Med Res. 2022 May;50(5):3000605221094644. doi: 10.1177/03000605221094644. J Int Med Res. 2022. PMID: 35579181 Free PMC article.
References
-
- Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, Li X, Wang L, Wang L, Liu Y, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London, England) 2019;394(10204):1145–1158. doi: 10.1016/S0140-6736(19)30427-1. - DOI - PMC - PubMed
-
- Wang C, Xu J, Yang L, Xu Y, Zhang X, Bai C, Kang J, Ran P, Shen H, Wen F, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet (London, England) 2018;391(10131):1706–1717. doi: 10.1016/S0140-6736(18)30841-9. - DOI - PubMed
-
- Maltais F, Decramer M, Casaburi R, Barreiro E, Burelle Y, Debigaré R, Dekhuijzen PNR, Franssen F, Gayan-Ramirez G, Gea J, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15–e62. doi: 10.1164/rccm.201402-0373ST. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
